TRANSFORMING CME IMPACT: MEDSCAPE’S GAME-CHANGING APPROACH
May 2, 2024 |
It’s time for the CME industry to evolve. During recent years, access to data, modern technologies, and methodologies have allowed for deeper analysis of data and a better understanding of the story the information tells us. However, the CME industry has been slower to adopt these advances compared to other industries and even departments within pharma. This is why Medscape Education is leading the industry by transforming the story of impact and insights derived from education to take a data-driven, evidence-led approach to CME.
(You can also download the full article here)
“By harnessing our proprietary data and technology, and exceptional talents that are a part of the Medscape Professional Network, we’re able to predict and achieve impact for every program we develop with a proven high degree of accuracy. What we’re creating is a dynamic, evolving continuum of CME programs designed to optimize our ability to positively influence healthcare professionals who are best positioned to impact patient care.”
Medscape’s ability to revolutionize impact and insights comes as a result of 29 years of experience as the largest CME provider in the world powered by a dedicated team of industry-leading talents. By making a significant investment in data, new technologies, and methodologies, Medscape is able to elevate the way they reach their audience, deliver education, and measure impact.
Introducing PULSE
“Our ability to evolve is unparalleled. As part of this, we’ve developed PULSE, the Precision, User, Learning, and Segmentation Engine—an industry-leadin g tool that allows us to identify the exact learners who need and are most poised to benefit from the education we develop and get the information into their hands. It’s a more precise, omnichannel approach to reaching healthcare professionals so they are presented with the education they need when they’re most receptive to learning, we are making sure those teachable moments are both intercepted and optimized. With this, we are embracing the most up to date technologies and preparing for its evolution.” Medscape’s proprietary technology, data, and platform allow for a range of impact measurement methods to identify what’s working for whom, when, and why.
(You can also download the full article here)
“Our new impact measurement is completely customized. We look carefully at each program and prepare a bespoke impact solution that will garner the data necessary to assess impact and guide future strategy. We’re taking the standard Moore’s Pyramid to the next level by holistically examining the stages of behavior change and identifying where we need to move the needle to see impact. We have the data and expert analytics skills to show a program is working, how it’s working, and transform that information into actionable insights. This is an area where anything is possible, and we’re really leaning into that.” Medscape has successfully begun developing education programs under the new impact paradigm, led by their Chief Impact Officer, Katie Lucero.
“We are excited to be at the forefront of the CME community’s evolution as we move toward the second quarter of the 21st century. Imagine the possibilities of CME when we truly approach it in a scientific way. We’re very proud of all the hard work that’s gone into making this possible. 2024 is going to be a big year!” – Katie Lucero PhD, Chief Impact Officer, Medscape Education
(You can also download the full article here)
About Medscape Education Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free accredited CME and CE courses for physicians, nurses, and other healthcare professionals.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
The Need for and Impact of Rare Disease Education
Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may...
Medscape Education: Rare Diseases Fibrodysplasia Ossificans Progressiva
Rare Disease Day is on February 28.Listen to Nicky explain her daughter's journey with fibrodysplasia ossificans progressiva.Many patients face long waits for accurate diagnosis and treatment, making it critically important...
Medscape Education: Rare Diseases
It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...
Together Caring for Rare Disease
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC
This year's winners have been announced for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...
Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?
Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...
DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE
During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...
ESMO’s New Focus on Cancer Prevention
During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...
ESMO Patient Centricity – Highlights from Steve Clark
During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK),...